Sponsor Pipeline

Sir Mortimer B. Davis - Jewish General Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
26
Active Trials
12
Recruiting
7
Phase 3
10
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-24 NCT02303327
Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients
date change Primary completion pushed: 2026-12 -> 2028-12
Active Trials by Phase
Phase 4
1
Phase 3
4
Phase 2/3
3
Phase 2
3
Not specified
15
Active Trials — top 25 of 26
NCT IDTitleConditionStatus
Phase 4
NCT07371728 Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery Otologic Disease Not Yet Recruiting
Phase 3
NCT05257629 Aggressive Smoking Cessation Trial (ASAP) Acute Coronary Syndrome Recruiting
NCT04150458 Fluorocholine PET/CT Basket Trial Fluorocholine PET/CT Enrolling by Invitation
NCT01444820 Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the… Prostate Cancer Active, Not Recruiting
NCT02303327 Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients Prostate Cancer Active, Not Recruiting
Phase 2/3
NCT03051464 Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery Stage II Rectal Cancer Recruiting
NCT03459820 Prostate Cancer Patient Management With 18F-DCFPyL PET/CT Prostate Cancer Enrolling by Invitation
NCT02685397 Management of Castration-Resistant Prostate Cancer with Oligometastases Castration-resistant Prostate Cancer Patients with Oligometastases Active, Not Recruiting
Phase 2
NCT06530524 Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery Head Neck Cancer Not Yet Recruiting
NCT07254962 CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE) Head Neck Cancer Not Yet Recruiting
NCT04070209 Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X) Metastatic Prostate Cancer Active, Not Recruiting
Not specified
NCT06521710 Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic… Prostate Cancer Recruiting
NCT02573636 The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate… Prostate Cancer Recruiting
NCT05530096 Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD Multiple Myeloma Recruiting
NCT05335174 Hypotension Prediction Index in Postoperative Surgical Patients Surgery Recruiting
NCT06888388 Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer… Breast Cancer Surgery Recruiting
NCT05139706 Montreal Immune-Related Adverse Events (MIRAE) Study Cancer Recruiting
NCT07188064 A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer… Prostate Cancer Recruiting
NCT07338500 Cardiovascular Effects of Music Versus Guided Mindfulness Music Listening Intervention Recruiting
NCT02333110 GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors Patients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to Radiation Recruiting
NCT04925154 Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to… Patient Preference Recruiting
NCT06458855 Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy Prostate Cancer Active, Not Recruiting
NCT07003880 Penthrox in Otolaryngology All Adult Patients Undergoing an Otolaryngology Procedure With Inhaled Methoxyflurane as an Adjunct to Topical or Local Anesthesia Not Yet Recruiting
NCT07140588 Pilot Study of a New Nerve Grafting Method During Bladder Cancer Surgery to Help Preserve… Bladder Cancer Requiring Cystectomy Not Yet Recruiting
NCT07538687 VR Study Virtual Reality for Patients During Arteriovenous Fistula Surgery End Stage Renal Disease on Dialysis Not Yet Recruiting
See all 26 active Sir Mortimer B. Davis - Jewish General Hospital trials with filters →
Disease Areas
Get alerts when Sir Mortimer B. Davis - Jewish General Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free